Loncom Pharma's Endocrine APIS, such as Ertugliflozin, Empagliflozin, Linagliptin, Prucalopride Succinate, and Vildagliptin, play a crucial role in antidiabetic and gastrointestinal medication development, providing targeted therapies for metabolic and endocrine disorders.
